Related Experiment Videos

Inactivation of penicillin G during experimental infection with Bacteroides fragilis

Insights

Penicillin G penetration into infection sites was reduced, and Bacteroides fragilis bacteria inactivated the drug. This animal model study highlights challenges in treating B. fragilis infections with penicillin G.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Bacteroides fragilis is a common cause of serious infections.
  • Penicillin G is a widely used antibiotic, but its efficacy against B. fragilis can be variable.

Purpose of the Study:

  • To investigate the penetration of penicillin G into sites infected with B. fragilis.
  • To determine the impact of B. fragilis infection on penicillin G concentrations in infected tissues.

Main Methods:

  • An animal model using rabbits with intraperitoneal plastic reservoirs was established.
  • Penicillin G concentrations were measured in infected and uninfected reservoirs.
  • Radiolabeled penicillin G was used to assess drug penetration and bioactivity.

Main Results:

  • Penicillin G penetration into uninfected capsules was 19.9%, significantly reduced to 1.5% in heavily infected capsules.
  • Radiolabeled penicillin G showed 12.5% penetration into infected capsules, but only 1% remained bioactive.
  • A modest reduction in penetration and striking inactivation by B. fragilis were observed.

Conclusions:

  • Bacteroides fragilis significantly reduces penicillin G penetration and bioactivity in infected tissues.
  • The findings suggest limitations in using penicillin G for B. fragilis infections due to drug inactivation.
  • Further research into alternative treatment strategies for B. fragilis infections is warranted.

Related Concept Videos